IBD in the Elderly Population: Results from a Population-based Study in Western Hungary, 1977-2008
Overview
Authors
Affiliations
Background And Aims: Limited data are available on the incidence and disease course of IBD in the elderly population. Our aim was to analyze the incidence and disease course of IBD according to the age at diagnosis in the population-based Veszprem province database, which included incident patients diagnosed between January 1, 1977 and December 31, 2008.
Methods: Data of 1420 incident patients were analyzed (UC: 914, age at diagnosis: 38.9 SD 15.9 years; CD: 506, age at diagnosis: 31.5 SD 13.8 years). Both hospital and outpatient records were collected and comprehensively reviewed.
Results: 106 (11.6%) of UC patients and 21 (4.2%) of CD patients were diagnosed with >60 years of age. In UC, the incidence increased from 1.09 to 10.8/10(5) in the elderly, while CD increased to 3.04/10(5) in 2002-2007. In CD, colonic location (elderly: 61.9% vs. pediatric: 24.3%, p=0.001, and adults: 36.8%, p=0.02) and stenosing disease (elderly: 42.9% vs. pediatric: 14.9%, p=0.005, and adults: 19.5%, p=0.01) were more frequent in the elderly. A change in disease behavior was absent in the elderly, while in pediatric and adult CD population it was 20.3% (p=0.037), 19.8% (p=0.036) after 5 years. In UC, extensive disease was more frequent in pediatric patients compared to the elderly (p=0.003, OR: 2.73, 95%CI: 1.38-5.41). In addition, pediatric (57.3%, p<0.001, OR: 6.58; 95%CI: 3.22-12.9) and adult (39.8%, p<0.001, OR: 3.24; 95%CI: 1.91-5.49) patients required more often systemic steroids during follow-up compared to the elderly (17%). Proximal extension at 10 years was 11.6%, but time to extension was not different according to the age at onset.
Conclusions: Elderly patients represent an increasing proportion of the IBD population. Stenosing and colon-only disease were characteristic for elderly CD patients, while the disease course in UC was milder.
Artificial Intelligence as a Tool in Diagnosing Inflammatory Bowel Disease in Older Adults.
Prada A, Stroie T, Diculescu R, Gogirla G, Radu C, Istratescu D J Clin Med. 2025; 14(4).
PMID: 40004890 PMC: 11856854. DOI: 10.3390/jcm14041360.
Angyal D, Gonczi L, Balogh F, Wetwittayakhlang P, Golovics P, Pandur T J Crohns Colitis. 2025; 19(1).
PMID: 39758021 PMC: 11772860. DOI: 10.1093/ecco-jcc/jjaf003.
Brunet-Mas E, Selva A, Bas-Cutrina F, Brujats A, Caballol B, Font R Clin Transl Gastroenterol. 2024; 16(2):e00740.
PMID: 39729123 PMC: 11845185. DOI: 10.14309/ctg.0000000000000740.
Yu Z, Ruan G, Bai X, Sun Y, Yang H, Qian J Chin Med J (Engl). 2024; 137(23):2851-2859.
PMID: 39501850 PMC: 11649283. DOI: 10.1097/CM9.0000000000003345.
Epidemiology of Inflammatory Bowel Disease across the Ages in the Era of Advanced Therapies.
Caron B, Honap S, Peyrin-Biroulet L J Crohns Colitis. 2024; 18(Supplement_2):ii3-ii15.
PMID: 39475082 PMC: 11522978. DOI: 10.1093/ecco-jcc/jjae082.